1 completed, 1 enrolling by invitation. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Cushing Disease Due to Increased ACTH Secretion: new trials by email Literature Review of Cushing Disease Due to Increased ACTH Secretion trials Research Report on Cushing Disease Due to Increased ACTH Secretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Osilodrostat and Cabergoline in Cushing's Disease osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion | Phase 4 | Enrolling by invitation | University of Basrah | 50 | 2026-05-11 | 2026-05-22 |
| SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome SPI-62, Placebo - Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion | Phase 2 | Completed | Sparrow Pharmaceuticals | 26 | 2022-09-01 | 2025-10-08 |
Pituitary ACTH Hypersecretion (2) · ACTH Syndrome, Ectopic (1) · Adrenal Insufficiency (1) · Cushing Syndrome (1) · Hyperandrogenism (1) · Hypertension (1) · Hypokalemia (1)
Adrenal Gland Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Endocrine System Diseases (2) · Hyperpituitarism (2) · Hypothalamic Diseases (2) · Nervous System Diseases (2) · Pituitary Diseases (2) · 46, XX Disorders of Sex Development (1) · Adrenocortical Hyperfunction (1) · Adrenogenital Syndrome (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disorders of Sex Development (1)
Cabergoline (1) · Osilodrostat (1)
Sparrow Pharmaceuticals (1) · University of Basrah (1)
Bulgaria (1) · Iraq (1) · Romania (1) · United States (1)
Abbas A Mansour (1) · Frank Czerwiec, MD (1) · Haider A Alidrisi (1) · Ibrahim H Hussein, MD (1)